International Research in Chinese Medicine

Objective: To analyze the value of flavored Astragalus Jianzhong decoction for diarrhea type irritable bowel syndrome. Methods: For the diarrhea patients (n=84) from August 2020 to July 2022,42 patients were each in the control group, the former used flavored Astragalus Jianzhong soup, and the latter underwent routine treatment. Compare the recurrence rate and other indicators. Results: Regarding the total response rate, the test group data was 97.62%, much higher than 80.95% in the control group (P <0.05). For the TCM syndrome score, at the end of the treatment: the test group data (4.02 ± 1.07) score was lower than the control group data (7.36 ± 1.38) score (P <0.05). On the recurrence rate: the trial group data was 4.76%, which was even lower than the 23.81% data in the control group (P <0.05). For sf-36 score: At the end of treatment, the trial group data (89.51 ± 2.63) score was higher than the control group data (80.42 ± 3.15) score (P <0.05). Conclusion: For diarrhea-type irritable bowel syndrome, there is a lower recurrence rate, a higher efficacy, a more rapid symptom relief, and a better improvement in the quality of life.

irritable bowel syndrome; Astragalus Jianzhong soup; recurrence rate; diarrhea type